Find clinical trials for Prostate Cancer in Philadelphia, PA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Prostate Cancer trials near Philadelphia, PA, USA:
of this study is to evaluate the safety, tolerability, and antitumour activity of AZD0754 CAR T-cell therapy in participants with metastatic prostate...
Phase 1, Phase 2
Philadelphia, Pennsylvania, United States and 8 other locations
This was a randomized study to evaluate the risk of major adverse cardiovascular events (MACE) for relugolix compared with leuprolide acetate. Enroll...
Phase 3
Bala-Cynwyd, Pennsylvania, United States and 107 other locations
Prostate cancer is usually treated by reducing the amount of testosterone in the body. PRL-02 depot is a potential treatment for me ...
Phase 1
Bala-Cynwyd, Pennsylvania, United States and 13 other locations
This study seeks to determine the clinical impact of Gene Expression Classifier (GEC) testing in prostate cancer care while also de...
Philadelphia, Pennsylvania, United States and 7 other locations
A Phase 1/2 study to evaluate the safety and efficacy of ARV-766 given by mouth alone or in combination with abiraterone in men with metastatic prostate...
Phase 1, Phase 2
Philadelphia, Pennsylvania, United States and 22 other locations
Evaluate the safety and tolerability of AMG 509 in adult participants and determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2...
Phase 1
Philadelphia, Pennsylvania, United States and 50 other locations
inhibitor, in Veterans with metastatic castration-resistant prostate cancer (mCRPC) characterized by either mismatch repair deficie...
Phase 2
Philadelphia, Pennsylvania, United States and 11 other locations
radiation therapy for patients with intermediate-high risk localized prostate cancer. ProstAtak kills tumor cells and stim...
Phase 3
Bala-Cynwyd, Pennsylvania, United States and 72 other locations
and abiraterone in patients with metastatic castration-resistant prostate cancer (mCRPC) who have received no prior cytotoxic chemo ...
Phase 3
Philadelphia, Pennsylvania, United States and 131 other locations
of vudalimab (XmAb20717) alone or in combination with standard of care anticancer therapies in patients with metastatic castration-resistant prostate...
Phase 2
Philadelphia, Pennsylvania, United States and 25 other locations
Clinical trials
Research sites
Resources
Legal